David Sugrue, B.S., is a 2015 Pharm.D. candidate; Robin Bogner, M.S., Ph.D., is Associate Professor of Pharmaceutics; and Megan J. Ehret, Pharm.D., M.S., BCPP, is Associate ...
KOL Resume for David Sugrue (hyperkinetic disorder, behavior, hyperkinetic disorders, disorders, hyperkinetic)
David Sugrue, B.S., is a 2015 Pharm.D. candidate; Robin Bogner, M.S., Ph.D., is Associate Professor of Pharmaceutics; and Megan J. Ehret, Pharm.D., M.S., BCPP, is Associate Professor of Pharmacy Practice, School of Pharmacy, University of Connecticut, Storrs
Prominent publications by David Sugrue
Methylphenidate and dexmethylphenidate formulations for children with attention-deficit/hyperactivity disorder
[ PUBLICATION ]
PURPOSE: Current literature on the safety and efficacy of various intermediate- and long-acting preparations of methylphenidate and dexmethylphenidate for pediatric attention-deficit/hyperactivity disorder (ADHD) is reviewed.
SUMMARY: The efficacy of methylphenidate in controlling ADHD symptoms is firmly established. Given the drug's relatively short half-life in pediatric patients (about 2.5 hours), a number of intermediate- and long-acting products have been developed; these ...
|Known for Hyperactivity Disorder | Adhd Symptoms | Attention Deficit | Extended Release | Methylphenidate Tablets|
David Sugrue: Influence Statistics
Key People For Hyperactivity Disorder
David Sugrue:Expert Impact
Concepts for whichDavid Sugruehas direct influence:Hyperactivity disorder, Deficit hyperactivity, Disorder hyperactivity, Disorder adhd, Methylphenidate tablets, Nervous stimulants, Stimulants child, Humans methylphenidate.
David Sugrue:KOL impact
Concepts related to the work of other authors for whichfor which David Sugrue has influence:Excessive blinking, Hyperactivity disorder, Laboratory classroom setting, Dopamine compartmentalization, Mpd adolescence, Young brain, Adults adhd.
Is this your profile? Claim your profile Copy URL Embed Link to your profile